Navigation Links
Curcumin may inhibit nicotine-induced activation of head and neck cancers
Date:10/4/2009

San Diego, CA Curcumin, the compound that gives curry powder its yellow/orange color, may inhibit the adverse effects of nicotine in patients with head and neck cancer who continue to smoke.

In a paper presented at the 2009 American Academy of Otolaryngology Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers examined the effects of curcumin on head and neck squamous cell carcinoma (HNSCC) growths. The study used an in vitro model of a variety of head and neck cancer cell lines. To mimic the clinical situation, HNSCC cells were pre-treated with curcumin and then nicotine was introduced. The results of the studies showed that the curcumin was able to block the nicotine from activating cancer causing cells.

Annually there are approximately 40,000 new cases of head and neck cancers and 13,000 deaths in the U.S. and 500,000 new cases worldwide. Recurrence of these cancers are high because many patients continue to smoke after successful treatment. Also, former smokers often use nicotine replacement therapy as an aid for successful tobacco cessation.

Although nicotine itself has not been shown to be carcinogenic, it has been shown to encourage the cancer-forming process. The researchers sought a safe, bioactive food compound that could be used not only as a chemopreventive agent but could also block the harmful effects of nicotine.

The results may help to discover additional therapies for cancer prevention and treatment.


'/>"/>

Contact: Jessica Mikulski
newsroom@entnet.org
703-535-3762
American Academy of Otolaryngology -- Head and Neck Surgery
Source:Eurekalert

1

GOOD

Page: 1

Related medicine news :

1. HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimers Disease
2. Inhibition of NF-kappa B, a key inflammatory protein, reduced radiation toxicity in zebrafish
3. Prodrug could help curb skin toxicity related to EGFR-inhibiting cancer drugs
4. Catalyst Pharmaceutical Partners Licenses Exclusive Rights to New Class of GABA Aminotransferase Inhibitors From Northwestern University
5. HerbalScience Research Identifies Key Bioactives in Nettle Extract That Inhibit Inflammation Associated with Seasonal Allergies
6. Surveyed Physicians Will Treat Over 50 Percent of Hepatitis C Genotype 1-Infected Patients With the Protease Inhibitor Telaprevir
7. HIV integrase inhibitor effective for patients beginning antiretroviral treatment
8. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
9. Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production
10. For Treatment of Type 2 Diabetes, 89 Percent of Surveyed Endocrinologists Identify a Need for Additional GLP-1 Analogues and 71 Percent Say the Same About DPP-IV Inhibitors
11. Pharmasset Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/13/2010)... today at the American Orthopaedic Society for Sports Medicine,s ... that 95 percent of skeletally mature high school pitchers ... Almost as many, (94.7 percent) returned to competitive baseball. ... a damaged elbow ligament (ulnar collateral ligament or UCL) ... body. The surgery is named for Hall of Fame ...
(Date:3/13/2010)... new mathematical model developed by Indiana University Bloomington and ... in the midst of passing or reforming sex offender ... first test in an Early View edition of ... users to quantify risk and issues of special concern, ... to focus on the spatial management of sex offenders ...
(Date:3/12/2010)... March 12 Though consumers have slowed frivolous ... on are things that make their daily life easier. Saving ... which is why Laser Hair Removal treatments are ... fact is that laser hair removal saves a ... investment that lasts for years, even a lifetime. Unlike waxing, ...
(Date:3/12/2010)... health care poll Monday, March 15 at NOON ET .  The poll surveys attitudes in 35 swing congressional districts regarding the ... ... , ... ... ...
(Date:3/12/2010)... March 12 Community Health Systems, ... president and chief executive officer, Wayne T. ... financial officer, Larry Cash , have been ... the number one investor relations company, CEO and ... sectors. This is the fourth consecutive year Smith ...
Breaking Medicine News(10 mins):Health News:'Tommy John' elbow reconstruction 95 percent successful with grown teen pitchers, study says 2Health News:Mathematical model can help communities better evaluate sex offender policies 2Health News:Mathematical model can help communities better evaluate sex offender policies 3Health News:Ring In the New Year With a Beautiful, Smooth Body 2Health News:Ring In the New Year With a Beautiful, Smooth Body 3Health News:Independent Women's Voice Releases Health Care Poll 2Health News:Community Health Systems, Inc.'s Wayne T. Smith and Larry Cash Named America's Top Healthcare CEO and CFO 2
... , "Super paper:" New nanopaper more break-resistant than ... and Japan report development of a new type of ... as cast iron. The new material, called "cellulose nanopaper," ... open the way for expanded use of paper as ...
... attended a specialist nurse clinic rather than a consultant-led ... frequent consultations and good symptom management, according to a ... Clinical Nursing. , And because the clinical nurse ... of the consultations without referring issues to the consultant, ...
... DETROIT, June 9 Rock Enterprises President and Chief,Operating ... of the,YMCA of Metropolitan Detroit. Cullen succeeds Bill Baer, ... "I am proud of the work the YMCA does ... and strong communities,",Cullen said. "The YMCA has been a ...
... /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX:,QLT) announced ... has,entered into an asset purchase agreement with Allergan ... AGN ) to fully divest QLT,s,worldwide rights ... United States and Canada for the treatment of ...
... research abstract that will be presented on Monday at ... Professional Sleep Societies (APSS), finds that poor sleep is ... study, authored by Julie L. Elam, of Indiana University, ... average age of 48 years. Seventy-six percent of ...
... may lower the risk of sleep problems in Caucasian women, ... research abstract that will be presented on Monday at SLEEP ... Societies (APSS). , The study, authored by Wendy M. Troxel, ... women from the Study of Womens Health Across the Nation, ...
Other Medicine News:Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 2Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 3Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 4Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 5Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 6Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 7Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 3Health News:Cullen Elected to Chairman of YMCA of Metro Detroit - the City's Oldest Not-for-Profit 2Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 2Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 4Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 5Health News:Poor sleep a problem in long-term breast cancer survivors 2Health News:More marital happiness = less sleep complaints 2
(Date:3/12/2010)... -- Eisai Inc. (Headquarters: Woodcliff Lake, New Jersey , Chairman and CEO: ... licensing agreement with the Johns Hopkins University ,s Brain Science Institute (Headquarters: ... Eisai,s GCPII (glutamate carboxypeptidase II) technology.   , ... ... ...
(Date:3/12/2010)... today announced financial results for the fourth quarter and year ended December 31, 2009 .   , ... , ... ... ... Novavax reported a net loss of $14 million , or $0.15 per share, for the fourth quarter of 2009 compared to ...
(Date:3/12/2010)... Taiwan , March 12 ... today the Phase II trial of ... with once-a-day dosing met the primary ... good tolerability. Nemonoxacin is a,novel non-fluorinated ... of activity against,gram-positive and gram-negative bacteria ...
Breaking Medicine Technology:Eisai Enters Licensing Agreement with Johns Hopkins Brain Science Institute 2Eisai Enters Licensing Agreement with Johns Hopkins Brain Science Institute 3NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results 2NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results 3NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results 4NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results 5NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results 6NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results 7NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results 8NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results 9NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results 10TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints 2TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints 3Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 1Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 2Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 3Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 4Hangovers May Be Tougher for Migraine Sufferers 59737 1Drugs for Irritable Bowel Might Increase Cancer Risk 59736 1Drugs for Irritable Bowel Might Increase Cancer Risk 59736 2
... the 42nd annual meeting of the European,Association for ... April 11, 2007 /PRNewswire-FirstCall/ --,Schering-Plough Corporation reaffirms its ... hepatitis C virus (HCV),infection with several key data ... the Liver (EASL) 42nd annual meeting,in Barcelona, Spain, ...
... - INNOVIVE Pharmaceuticals,Inc. (OTCBB:IVPH) today announced that ... INNO-406, an orally bioavailable dual Bcr-Abl and,Lyn-kinase ... will be presented at the American,Association for ... INNO-206, a doxorubicin prodrug for the,treatment of ...
Other Medicine Technology:Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 2Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 3Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 4Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 5Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 6Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C 7Innovive Pharmaceuticals Announces Data from Oncology Drug Programs,to be Presented at American Association for Cancer Research Annual,Meeting 2Innovive Pharmaceuticals Announces Data from Oncology Drug Programs,to be Presented at American Association for Cancer Research Annual,Meeting 3
This table has adjustable height, round post, and universal clamp. Replacement 1" (5 cm) or 2" (2.5 cm) pad sold separately....
This table has adjustable height, square post and adjustable leg. Includes clamps, and standard 1" (2.5 cm) pad....
Built-in accessory rail clamps quickly mount to any standard O.R. table or stretcher. The leg, available in single post or double tee adjusts with a simple twist. Optional armrests are available. Wal...
... versatile model angulates for vascular procedures. ... height of the support leg, which ... or double tee foot. Add up ... and stability. A convenient bracket is ...
Medicine Products: